NCT07099365

Brief Summary

This study is a two-arm, randomised controlled cross-over feasibility study with a nested, optional qualitative study. The intervention consists of a self-guided smartphone app (Orbi) based on cognitive behavioural therapy (CBT) principles, which is designed to support psychological adjustment in long-term physical conditions. Orbi is an app adaption of an existing, evidence-based web-based intervention COMPASS. The control condition consists of usual charity support (UCS) for the relevant long-term physical health conditions (LTCs). All charity support includes a helpline which can be accessed via telephone or email. The goal of this trial is to evaluate the feasibility of Orbi and the main questions it aims to answer are:

  • Be randomised and each participant has an equal (50 %) chance of being assigned either to the Orbi+UCS group or to UCS group alone for 12 weeks. After 12 weeks, they will be crossed over to the alternate condition for another 12 weeks
  • Complete questionnaires to assess psychological distress and intervention engagement at baseline, 6 weeks, and 12 weeks.
  • A subset of participants will be invited to take part in a nested, optional semi-structured interviews to explore their experiences using Orbi and participating in the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 10, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 1, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 23, 2026

Completed
Last Updated

August 7, 2026

Status Verified

January 1, 2025

Enrollment Period

12 months

First QC Date

July 25, 2025

Last Update Submit

August 4, 2026

Conditions

Keywords

anxietydepressionpsychological distresschronic diseasecognitive behavioural therapy

Outcome Measures

Primary Outcomes (4)

  • Recruitment

    Frequencies and percentages of the number of potential participants recruited to the study

    At baseline

  • Retention

    Frequencies and percentages of the number of participants retained in the study

    At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

  • Reach

    Frequencies and percentages of recruited participants who are from under-represented ethnic groups for research conducted in the United Kingdom (e.g. ethnic groups other than white British)

    At baseline

  • Acceptability

    Quantitative: Frequencies and percentages or means and standard deviations of the Theoretical Framework of Acceptability (TFA) questionnaire Qualitative: Framework Thematic Analysis

    6 weeks (mid-study) and 12 weeks (end of study)

Secondary Outcomes (13)

  • App usability

    6 weeks (mid-study) and 12 weeks (end of study)

  • Primary adherence and engagement: App usage data

    6 weeks (mid-study) and 12 weeks (end of study)

  • Compare post intervention scores on Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS-15) adjusting for baseline differences between groups

    At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

  • Compare post intervention scores on Patient Health Questionnaire Scale - (PHQ-8) adjusting for baseline differences between groups

    At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

  • Compare post intervention scores on Generalised Anxiety Disorder Scale (GAD-7) adjusting for baseline differences between groups

    At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

  • +8 more secondary outcomes

Study Arms (2)

Orbi + Usual Charity Support (UCS)

EXPERIMENTAL

Participants randomised to this condition receive access to a self-guided smartphone app (Orbi) based on cognitive behavioural therapy principles in addition to Usual Charity Support (Orbi + UCS) to support Psychological Adjustment in long-term physical conditions.

Device: Orbi

Usual Charity Support (UCS)

NO INTERVENTION

Participants randomised to this condition access Usual Charity Support (UCS) for their long-term physical condition(s). Resources provided by the charities include supportive listening, online support groups, information resources and local community support groups.

Interventions

OrbiDEVICE

Orbi is adapted from COMPASS, a web-based cognitive behavioural therapy (CBT) intervention based on the Transdiagnostic Model of Adjustment in Long-Term (physical) Conditions Model. Orbi is made up of 13 topics, each exploring a different challenge faced by individuals with a LTC(s). Orbi is a self-guided CBT programme with no therapist involvement.

Orbi + Usual Charity Support (UCS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged ≥18-years
  • Verbal and written proficiency in English
  • United Kingdom resident (General Practitioner registered)
  • Basic computer literacy
  • Email address to register with Orbi
  • Have a long-term physical health condition
  • Are experiencing distress related to their long-term physical condition

You may not qualify if:

  • Evidence of substance dependency, cognitive impairment, severe mental health conditions identified by adhering to usual care Improving Access to Psychological Therapies (IAPT) screening practices that are employed at assessment and triage
  • Those with evidence of severe depression and/ or anxiety scoring over 6 on the Patient Health Questionnaire-4 (PHQ-4) eligibility questionnaire or scoring 1 or above on the eligibility Patient Health Questionnaire-9 (PHQ-9) suicide risk question
  • Receiving active psychological treatment from psychologist/counsellor/therapist or online psychological intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Psychology Department, King's College London

London, London, SE1 9RT, United Kingdom

Location

Related Publications (4)

  • Carroll S, Moon Z, Hudson J, Hulme K, Moss-Morris R. An Evidence-Based Theory of Psychological Adjustment to Long-Term Physical Health Conditions: Applications in Clinical Practice. Psychosom Med. 2022 Jun 1;84(5):547-559. doi: 10.1097/PSY.0000000000001076. Epub 2022 Apr 12.

    PMID: 35412516BACKGROUND
  • Hulme K, Hudson JL, Picariello F, Seaton N, Norton S, Wroe A, Moss-Morris R. Clinical efficacy of COMPASS, a digital cognitive-behavioural therapy programme for treating anxiety and depression in patients with long-term physical health conditions: a protocol for randomised controlled trial. BMJ Open. 2021 Oct 25;11(10):e053971. doi: 10.1136/bmjopen-2021-053971.

    PMID: 34697123BACKGROUND
  • Picariello F, Hulme K, Seaton N, Hudson JL, Norton S, Wroe A, Moss-Morris R. A randomized controlled trial of a digital cognitive-behavioral therapy program (COMPASS) for managing depression and anxiety related to living with a long-term physical health condition. Psychol Med. 2024 Jun;54(8):1796-1809. doi: 10.1017/S0033291723003756. Epub 2024 Feb 14.

    PMID: 38350600BACKGROUND
  • Seaton N, Moss-Morris R, Hulme K, Macaulay H, Hudson J. A cognitive-behavioural therapy programme for managing depression and anxiety in long-term physical health conditions: mixed-methods real-world evaluation of the COMPASS programme. BJPsych Open. 2023 Aug 11;9(5):e153. doi: 10.1192/bjo.2023.519.

    PMID: 37563762BACKGROUND

MeSH Terms

Conditions

DepressionAnxiety DisordersChronic Disease

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Rona Moss-Morris, PhD

    King's College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2025

First Posted

August 1, 2025

Study Start

June 10, 2025

Primary Completion

June 1, 2026

Study Completion

July 23, 2026

Last Updated

August 7, 2026

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

The data that support the findings of this study will be available on request from the corresponding author. The data will not be available publicly due to privacy or ethical restrictions.

Shared Documents
CSR
Access Criteria
The data will only be available on request.

Locations